Europe PMCopen access
Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial
Influenza, Immunogenicity, Respiratory syncytial virus, Mrna Vaccine, Coadministration, Mrna-1345
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 205423
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.